Division of Translational Cancer Research
591 – 600 of 661
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
MYC Synergizes with Activated BRAFV600E in Mouse Lung Tumor Development by Suppressing Senescence.
(
- Contribution to journal › Article
-
Mark
Functional subsets of mesenchymal cell types in the tumor microenvironment.
(
- Contribution to journal › Scientific review
-
Mark
The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
CYLD regulates HGF expression in hepatic stellate cells via interaction with HDAC7.
(
- Contribution to journal › Article
-
Mark
SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia.
(
- Contribution to journal › Article
-
Mark
A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse.
(
- Contribution to journal › Article
-
Mark
The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.
(
- Contribution to journal › Article
-
Mark
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
(
- Contribution to journal › Article
-
Mark
Infiltration of CD3(+) and CD68(+) cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
(
- Contribution to journal › Article